Oxygenta Pharmaceutical Ltd

Oxygenta Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Oxygenta Pharmaceutical Ltd

₹ 77.6 1.17%
29 Aug - close price
ssorganics.co.in BSE: 524636
About

Incorporated in 1990, Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.

Key Points

Products:[1]
Losartan potassium intermediate, Gabapentin intermediate, Antihypertensive drugs, Anti
cancer drugs, Antiulcer drugs, Antiretroviral drugs, Antihypertensive drugs, Antiviral drugs.

Website BSE
  • Market Cap ₹ 287 Cr.
  • Current Price ₹ 77.6
  • High / Low ₹ 134 / 36.2
  • Stock P/E
  • Book Value ₹ -6.93
  • Dividend Yield 0.00 %
  • ROCE -33.4 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Debtor days have improved from 68.2 to 17.0 days.
  • Promoter holding has increased by 6.80% over last quarter.
  • Company's median sales growth is 27.9% of last 10 years

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
8.89 6.06 7.85 8.19 6.86 13.08 9.15 10.55 12.62 14.01 33.21 49.47 15.13
9.93 7.56 10.18 10.44 10.50 15.06 11.63 12.17 14.40 16.18 37.57 51.15 21.96
Operating Profit -1.04 -1.50 -2.33 -2.25 -3.64 -1.98 -2.48 -1.62 -1.78 -2.17 -4.36 -1.68 -6.83
OPM % -11.70% -24.75% -29.68% -27.47% -53.06% -15.14% -27.10% -15.36% -14.10% -15.49% -13.13% -3.40% -45.14%
0.00 -0.34 -0.32 -0.05 -0.13 -0.03 -0.02 0.26 0.02 0.75 0.49 -0.22 0.16
Interest 0.25 0.10 0.20 0.94 0.29 0.34 0.36 0.59 0.41 0.69 0.39 2.13 0.63
Depreciation 0.40 0.40 0.40 0.85 0.50 0.83 0.69 0.64 0.65 0.66 0.71 -0.23 0.85
Profit before tax -1.69 -2.34 -3.25 -4.09 -4.56 -3.18 -3.55 -2.59 -2.82 -2.77 -4.97 -3.80 -8.15
Tax % 0.00% 0.00% 0.00% 4.89% 0.00% -0.63% 6.48% -409.27% -51.42% 2.89% -20.72% -43.42% -25.03%
-1.69 -2.34 -3.25 -4.29 -4.56 -3.16 -3.78 8.02 -1.36 -2.85 -3.93 -2.15 -6.11
EPS in Rs -1.19 -1.65 -2.29 -3.02 -1.36 -0.94 -1.13 2.40 -0.38 -0.80 -1.06 -0.58 -1.65
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
2 6 12 8 13 21 14 52 61 31 40 109 112
6 10 16 13 17 23 22 48 59 38 49 119 127
Operating Profit -3 -4 -4 -5 -4 -2 -8 4 1 -7 -10 -10 -15
OPM % -142% -67% -34% -59% -31% -10% -57% 7% 2% -23% -24% -9% -13%
0 0 0 1 1 0 4 2 1 -1 0 1 1
Interest 0 0 1 1 1 1 1 2 1 1 2 2 4
Depreciation 1 3 1 1 1 1 1 1 2 2 3 4 2
Profit before tax -4 -7 -6 -6 -4 -3 -6 3 -0 -11 -14 -14 -20
Tax % 5% -11% 0% 2% 1% -7% -3% 7% 24% 2% -75% -28%
-4 -6 -6 -6 -5 -3 -6 3 -1 -12 -3 -10 -15
EPS in Rs -4.21 -5.99 -5.39 -5.70 -4.44 -3.19 -5.68 2.87 -0.43 -8.15 -1.04 -2.79 -4.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 33%
5 Years: 51%
3 Years: 22%
TTM: 146%
Compounded Profit Growth
10 Years: -10%
5 Years: -1%
3 Years: %
TTM: -3182%
Stock Price CAGR
10 Years: 26%
5 Years: %
3 Years: 39%
1 Year: 101%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 10 10 10 10 10 10 10 14 14 33 37
Reserves -19 -26 -32 -38 -42 -45 -51 -48 -49 -60 -54 -63
11 15 17 19 19 22 27 48 52 68 57 62
17 19 24 27 30 34 33 24 14 32 26 46
Total Liabilities 18 18 20 19 17 21 19 34 31 54 63 83
16 12 13 12 12 12 11 16 20 28 29 37
CWIP 0 0 0 0 0 0 0 1 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
2 6 7 6 5 9 7 17 11 26 34 46
Total Assets 18 18 20 19 17 21 19 34 31 54 63 83

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-3 -4 1 1 1 -8 -3 -2 -2 -2 -13 3
-2 1 -2 -1 -0 -1 -0 -7 -5 -10 -4 -11
4 3 1 0 -1 8 3 9 6 11 17 9
Net Cash Flow -1 0 -0 0 -0 0 0 0 -0 -0 -0 0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 128 38 44 39 14 9 11 11 10 120 68 17
Inventory Days 33 84 41 122 57 121 100 121 56 178 149 78
Days Payable 10,165 1,800 667 599 396 203 190 137 50 362 249 113
Cash Conversion Cycle -10,004 -1,678 -582 -439 -325 -73 -79 -5 16 -64 -32 -18
Working Capital Days -1,576 -616 -454 -512 -438 -164 -275 -14 8 -94 -89 -184
ROCE % -188% -1% -47% -42% -33%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
12.34% 12.34% 8.99% 26.80% 29.73% 29.73% 29.73% 33.68% 53.28% 51.12% 51.12% 57.92%
0.07% 0.07% 0.07% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
87.60% 87.60% 90.95% 73.18% 70.24% 70.24% 70.24% 66.28% 46.69% 48.84% 48.84% 42.06%
No. of Shareholders 9,0009,1018,9958,9878,9729,05110,1029,97010,15410,10710,03010,094

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports